Both in Pharmaceuticals
Artelo Biosciences vs Matinas BioPharma Holdings
Over the past year ARTL returned −97.3% and MTNB returned −92.7%; their daily moves had a correlation of -0.01.
ARTL −97.3% MTNB −92.7%Growth of $1, one year, split-adjusted
| Metric | ARTL | MTNB |
|---|---|---|
| Price | $2.22 | $1.51 |
| Market cap | $1.2M | $1.5M |
| Today | −3.90% | −20.53% |
| 1 month | −42.0% | −37.6% |
| 6 months | −92.7% | −85.6% |
| Year to date | −93.3% | −82.8% |
| 1 year | −97.7% | −92.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $4.2M | $755.0K |
| Dividend yield | — | — |
| Volatility (60d) | 650.2% | 775.0% |
| Short % of float | 0.8% | 0.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).